Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-04-01
著者
-
Araki Kazuhiro
Department Of Medical Oncology Comprehensive Cancer Center Saitama Medical University
-
Sasaki Yasutsuna
Department Of Clinical Oncology And Medical Oncology International Medical Center Saitama Medical Un
-
Saji Shigehira
Department Of Breast Surgery Tokyo Metropolitan Komagome Hospital
-
Sasaki Yasutsuna
Department Of Medical Oncology International Medical Center Saitama Medical University
-
GALLAS Michelle
Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine
-
PEGRAM Mark
Braman Family Breast Cancer Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine
-
Pegram Mark
Braman Family Breast Cancer Institute Sylvester Comprehensive Cancer Center University Of Miami Miller School Of Medicine
-
Gallas Michelle
Braman Family Breast Cancer Institute Sylvester Comprehensive Cancer Center University Of Miami Miller School Of Medicine
-
Araki Kazuhiro
Department Of Medical Oncology International Medical Center Saitama Medical University
-
SAJI Shigehira
Department of Target Therapy Oncology, Kyoto University, Graduate School of Medicine
関連論文
- Oral analgesia by non-steroidal anti-inflammatory drug zaltoprofen to manage cystoscopy-related pain : A prospective study
- Usefulness of panoramic views for novice surgeons doing retroperitoneal laparoscopic nephrectomy
- Renal cell carcinoma with a huge solitary metastasis to the contralateral adrenal gland : A case report
- The role of testosterone in the pathogenesis of prostate cancer
- The efficacy and safety of laparoscopic nephrectomy in patients with three or more comorbidities
- The usefulness of ureterorenoscopic examination of evaluation of upper tract disease
- Early breast cancer
- Current Status of Antibody Therapy for Breast Cancer
- Clinical Impact of Assay of Estrogen Receptor βcx in Breast Cancer
- Weekly Schedule of Docetaxel in Breast Cancer: Evaluation of Response and Toxicity
- Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)(Miscellaneo
- CYP2A6 and the plasma level of 5-chloro-2,4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
- Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer
- Novel Single Nucleotide Polymorphism of UGT1A9 Gene in Japanese
- Novel Single Nucleotide Polymorphism of UGT1A7 Gene in Japanese
- MDM2 in Breast Cancer
- Acute gefitinib-induced pneumonitis
- Challenges in predicting the clinical outcome in S-1-based chemotherapy for gastric cancer patients
- Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia : A prospective study
- Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
- Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach
- Novel Sensitizing Agents : Potential Contribution of COX-2 Inhibitor for Endocrine Therapy of Breast Cancer
- Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast
- Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1^*28 and/or UGT1A1^*6 polymorphisms
- Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol
- Trends in local therapy application for early breast cancer patients in the Japanese Breast Cancer Society Breast Cancer Registry during 2004-2009
- Possible available treatment option for early stage, small, node-negative, and HER2-overexpressing breast cancer